The US Food and Drug Administration (FDA) has published guidance for dietary supplement manufacturers on what it considers to be sufficient scientific substantiation for the health claims made on their products.
As the year draws to a close, NutraIngredients-USA.com looks at occasions where the US FDA has intervened to clear up the food, drink and supplement industries of products that overstep the fine line between function and pharmaceutical.
In response to a recent BMJ editorial claiming that only drugs are effective for weight loss, members of the global food and supplements industries have defended the efficacy of their products, calling the article the “latest misinformed campaign”.
Lorraine Heller talks to Danisco’s director of regulatory and scientific affairs in North America – Stuart Craig – who predicts an environment of increased regulation for the nutraceuticals and functional food markets.
In a move that has divided industry, the Food and Drug Administration (FDA) has told German pharma giant Bayer in no uncertain terms to cease making disease reduction claims about products that contain both pharmaceutical and nutraceutical ingredients.
Chrysantis said it is developing its eye-health ingredient zeaxanthin for use in food and beverages as the company announced it is boosting its sales force to meet growing demand in the supplement sector.
At the end of last month, the founder of US supplements firm Berkeley Premium Nutraceuticals received the most severe punishment yet to be handed out for fraud in the industry: A 25-year jail sentence and $93,000 from his personal savings. The company...
The US Food and Drug Administration estimates that it will receive only one nutrient content claim notification and two health claim notifications per year, according to a notice to be published in the Federal Register.